Method devised for diagnosis of ocular diseases

GAIKER-IK4 Technological Centre's Area of Biotechnology, together with the Opthtalmological Surgery Clinical Institute of Bilbao (ICQO) are co-operating in a research project the aim of which is to develop a diagnostic system, based on immunochromatographic techniques, for the specific recognition of proteic markers for ocular pathologies in eye teardrop samples.

This system, carried out with a swab (similar to pregnancy testing), will initially detect specific markers for ocular pathologies such as conjunctivochalasis and keratoconus and will enable, with a sample of teardrop liquid, the diagnosis of the patient with these disorders.

The ease of use of the system and both its speed and simplicity (a positive testing sign in the form of a coloured band) enables the system to be employed on a daily basis in the clinic. The markers on which the design of this diagnostic system is based are being analysed throughout the research project and validated by means of their recognition by specific antibodies in samples from the tears of patients affected by these pathologies.

In the future, towards the end of 2008, those responsible for the project hope to develop a multiple system, capable of detecting the presence of other ocular pathologies, besides the two already established in the initial phase, and with the aim of launching the diagnostic tests on the market.

Pathologies studied

Keratoconus or conic cornea condition is a disorder of the human eye which rarely causes blindness but can considerably interfere with vision. This pathology distorts the usual rounded shape of the cornea and forms acone-shaped prominence. It occurs in one in every two thousand persons and generally it coincides with puberty. Keratoconus does not follow any known geographical cultural or social pattern.

Conjunctivochalasis is the relaxation of the bulbar conjunctive capable of creating conjunctive folds over the lower palp

Contact: Irati Kortabitarte
Elhuyar Fundazioa

Page: 1 2

Related biology news :

1. Methodist, University of Houston, Cornell combine biomedical imaging expertise
2. Plants, plasmids and possibilities -- Methods permit functional gene studies in plants
3. Methodist Neurological Institute, University of Houston combine brain power
4. Method slashes quantum dot costs by 80 percent
5. Method holds promise in identifying markers of non-metastatic vs. metastatic breast cancer
6. Method shows how precisely gene expression signals are copied in DNA replication
7. Methodist, UH system joining forces for biomedical research, clinical care
8. MIDI, Inc receives Official Methods(SM) status for the confirmatory ID of the anthrax pathogen
9. Gold nanoparticles may pan out as tool for cancer diagnosis
10. Purdue-IU researchers explore new method for early disease diagnosis
11. New genetic test developed at Emory advances detection and diagnosis of muscular dystrophy

Post Your Comments:

(Date:11/4/2015)... York , November 4, 2015 ... a new market report published by Transparency Market Research "Home ... Growth, Trends and Forecast 2015 - 2022", the global home ... US$ 30.3 bn by 2022. The market is estimated ... forecast period from 2015 to 2022. Rising security needs ...
(Date:10/29/2015)... 29, 2015  The J. Craig Venter Institute (JCVI) ... Synthesis and Biosecurity: Lessons Learned and Options for the ... and Human Services guidance for synthetic biology providers has ... --> --> Synthetic biology ... potential to pose unique biosecurity threats. It now is ...
(Date:10/29/2015)... BOSTON , Oct. 29, 2015  Connected health ... phenomena driving the explosion of technology-enabled health and wellness, ... his new book, The Internet of Healthy ... apps, sensors or smartphones even existed, Dr. Kvedar, vice ... model of health care delivery, moving care from the ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... Dec. 1, 2015  An interventional radiology technique shows promise ... preliminary results of a study being presented today at the ... America (RSNA). --> ... decades by interventional radiologists as a way to stop bleeding ... as a means of treating obesity is new. ...
(Date:11/30/2015)... /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith" or the "Company") today ... to its Board of Directors to replace Dr. ... wealth of experience as co-founder of Resverlogix, with expertise in ... --> --> Dr. Wong remarked, "I am ... Zenith,s long standing expertise in epigenetics and the advanced stage ...
(Date:11/30/2015)... TapImmune, Inc. (TPIV), a ... peptide and gene-based immunotherapeutics and vaccines for the treatment ... be presenting at the 8 th Annual LD ... PM PT. Dr. John N. Bonfiglio a ... the presentation and will join TapImmune management in meeting ...
(Date:11/30/2015)...  Northwest Biotherapeutics (NASDAQ: NWBO ) ("NW Bio"), ... for solid tumor cancers, announced today that the Board ... the Company welcomes Neil Woodford,s call for ... internet report on NW Bio.  The Company,s Board is ... stated, "We agree with Mr. Woodford that, at ...
Breaking Biology Technology:
Cached News: